Abstract
Clarithromycin resistance in Helicobacter pylori is due to point mutation within the 23S rRNA. We examined the growth rates of different types of site-directed mutants and demonstrated quantitatively the competitive growth advantage of A-to-G mutants over other types of mutants by a multiplex sequencing assay. The results provide a rational explanation of why A-to-G mutants are predominantly observed among clarithromycin-resistant clinical isolates.
Original language | English (US) |
---|---|
Pages (from-to) | 683-685 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 43 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1999 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases